# MK0767 in Type 2 Diabetes (0767-012)

> **NCT00543556** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 514 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** MK0767

## Key facts

- **NCT ID:** NCT00543556
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-10
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 514 (ACTUAL)
- **Last updated:** 2015-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543556, "MK0767 in Type 2 Diabetes (0767-012)". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00543556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*